- MHRA approves Xevudy (sotrovimab), a COVID-19 treatment found to cut hospitalisation and death by 79%
- Precautionary recall of specific batches of blood pressure drug irbesartan
- MHRA statement on expansion of the COVID-19 vaccination booster programme
- MHRA welcomes today’s announcement by the JCVI
- Life-saving adrenaline auto-injectors could become available in public places
- Labelling error leads to retail-level recall of cold and flu medicine
- First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA
- MHRA’s new Chief Healthcare Quality and Access Officer begins important role
- Every report counts: support the Yellow Card scheme by reporting suspected side effects
- MHRA publishes clear guidance to support bringing e-cigarettes to market as licensed therapies
- UK, USA and Canadian regulators identify 10 guiding principles to be addressed when medical devices use AI or machine learning software
- Tesco Max All-In-One Chesty Cough & Cold Lemon Sachets are being recalled
- Innovative Licensing and Access Pathway (ILAP): New partner announcement
- Transforming the regulation of software and artificial intelligence as a medical device
- MHRA launches public consultation on future of medical device regulation
TSET - Technical Specialist Education and Training Group
News and communications from MHRA
By TSETadmin